95.23 - 97.14
55.47 - 103.81
1.63M / 1.80M (Avg.)
55.57 | 1.74
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
0.88%
Revenue growth of 0.88% while SA is flat. Bruce Berkowitz would check if a small edge can widen further.
9.53%
Gross profit growth of 9.53% while SA is zero. Bruce Berkowitz would see if minimal improvements could expand further.
8.65%
EBIT growth 50-75% of SA's 12.63%. Martin Whitman would suspect suboptimal resource allocation.
8.65%
Operating income growth at 50-75% of SA's 12.63%. Martin Whitman would doubt the firm’s ability to compete efficiently.
10.43%
Net income growth above 1.5x SA's 6.34%. David Dodd would check if a unique moat or cost structure secures superior bottom-line gains.
7.14%
EPS growth at 50-75% of SA's 9.79%. Martin Whitman would suspect a lag in operational efficiency or a higher share count.
7.14%
Diluted EPS growth at 50-75% of SA's 9.79%. Martin Whitman would question if share issuance or modest net income gains hamper progress.
0.07%
Share reduction more than 1.5x SA's 3.76%. David Dodd would see if the company is taking advantage of undervaluation to retire shares.
0.09%
Diluted share reduction more than 1.5x SA's 3.76%. David Dodd would validate if the company is aggressively retiring shares or limiting option exercises.
No Data
No Data available this quarter, please select a different quarter.
3.97%
OCF growth under 50% of SA's 82.17%. Michael Burry might suspect questionable revenue recognition or rising costs.
4.72%
Positive FCF growth while SA is negative. John Neff would see a strong competitive edge in net cash generation.
141.61%
10Y CAGR of 141.61% while SA is zero. Bruce Berkowitz would see if incremental growth can widen into a significant edge.
-20.62%
Negative 5Y CAGR while SA stands at 0.00%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
8.81%
3Y CAGR of 8.81% while SA is zero. Bruce Berkowitz would see if small gains can accelerate to a more decisive lead.
124.63%
10Y OCF/share CAGR above 1.5x SA's 57.38%. David Dodd would check if a superior product mix or cost edge drives this outperformance.
-42.27%
Both show negative mid-term OCF/share growth. Martin Whitman might suspect a challenged environment or large capital demands for both.
-1.57%
Both face negative short-term OCF/share growth. Martin Whitman would suspect macro or cyclical issues hitting them both.
48.42%
Similar net income/share CAGR to SA's 44.66%. Walter Schloss would see parallel tailwinds or expansions for both firms.
-61.72%
Negative 5Y net income/share CAGR while SA is 42.12%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
-13.79%
Negative 3Y CAGR while SA is 62.07%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
238.97%
10Y equity/share CAGR 1.25-1.5x SA's 159.99%. Bruce Berkowitz would see if strong ROE or conservative payout policy fosters faster book value growth.
41.60%
5Y equity/share CAGR above 1.5x SA's 24.85%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
16.36%
3Y equity/share CAGR similar to SA's 17.90%. Walter Schloss sees both having parallel profitability or reinvestment over 3 years.
No Data
No Data available this quarter, please select a different quarter.
-34.46%
Negative 5Y dividend/share CAGR while SA stands at 0.00%. Joel Greenblatt sees a weaker commitment to dividends vs. a competitor that might be growing them.
-5.82%
Negative near-term dividend growth while SA invests at 0.00%. Joel Greenblatt sees a weaker short-term distribution policy unless justified by strategic spending.
13.77%
AR growth is negative/stable vs. SA's 131.72%, indicating tighter credit discipline. David Dodd confirms it doesn't hamper actual sales.
No Data
No Data available this quarter, please select a different quarter.
-1.47%
Negative asset growth while SA invests at 14.29%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
1.03%
Under 50% of SA's 9.37%. Michael Burry raises concerns about the firm’s ability to build intrinsic value relative to its rival.
-10.43%
We’re deleveraging while SA stands at 0.00%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
No Data
No Data available this quarter, please select a different quarter.
15.14%
We expand SG&A while SA cuts. John Neff might see the competitor as more cost-optimized unless we expect big payoffs from the overhead growth.